输入性耐药间日疟合并急性扁桃腺炎一例  

Imported case of drug-resistant vivax malaria complicated with aute tonsillitis

作　　者：贺琴 刘园园 雷旭 谭华炳 

机构地区：[1]湖北医药学院附属人民医院感染性疾病科,十堰市442000 [2]湖北医药学院附属人民医院药学部,十堰市442000

出　　处：《中华实验和临床感染病杂志（电子版）》2017年第2期201-203,共3页Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)

基　　金：2014年湖北医药学院教学研究立项项目(No.2014058)

摘　　要：目的提高对输入性间日疟耐药以及并发症导致疟疾热型不典型的认识。方法分析1例输入性耐药间日疟合并急性扁桃腺炎患者的诊治过程,分析诊治其过程中识别并发症和疟原虫耐药。探讨疟原虫耐药的现状以及耐药疟原虫感染者的治疗。结果当前输入性疟疾是我国疟原虫感染的主要类型,疟原虫耐药发生率较高。临床诊治输入性间日疟时,不仅要注意间日疟耐药问题,还要注意并发症问题。结论科学诊断、治疗和预判是提高输入性疟疾疗效的关键。Objective To enhance the level of awareness on drug-resistantce of imported vivax malaria and atypical fever caused by complication. Methods The process of diagnosis and treatment of one imported case of drug-resistant vivax malaria complicated with acute tonsillitis were described to identify complication and drug resistance. While the drug resistance status of Plasmodium and treatment were also analyzed. Results At present, the imported malaria is the main type of malaria infection and has high rate of drug resistance in China. The physician should not only focus on the drug-resistance of vivax malaria, but also should pay attention to the complication. Conclusion Scientifc diagnosis, treatment and prediction are the keys to improve the effect of imported vivax malaria.

关 键 词：间日疟 输入性 耐药 扁桃腺炎 并发症 

分 类 号：R531.3[医药卫生—内科学]